NCT00974675View on ClinicalTrials.gov

A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma

PHASE1TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 29, 2006

Primary Completion Date

August 3, 2007

Study Completion Date

August 3, 2007

Conditions
Moderate Asthma
Interventions
BIOLOGICAL

CAT-354 1mg/kg

CAT-354 1 mg/kg of body weight intravenous infusion over 30 minutes on Day 0, 28 and 56.

BIOLOGICAL

CAT-354 5 mg/kg

CAT-354 5 mg/kg of body weight intravenous infusion over 30 minutes on Day 0, 28 and 56.

BIOLOGICAL

CAT-354 10mg/kg

CAT-354 10 mg/kg of body weight intravenous infusion over 30 minutes on Day 0, 28 and 56.

OTHER

Placebo

Placebo matched to CAT-354 intravenous infusion over 30 minutes on Day 0, 28 and 56.

Trial Locations (1)

SL1 2AD

Chiltern International Limited, Slough

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY

NCT00974675 - A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma | Biotech Hunter | Biotech Hunter